Drug Price Trends for NDC 49483-0619

Average Pharmacy Cost for 49483-0619

Drug Name	NDC	Price/Unit ($)	Unit	Date
NAPROXEN 250 MG TABLET	49483-0619-50	0.04809	EACH	2025-04-23
NAPROXEN 250 MG TABLET	49483-0619-01	0.04809	EACH	2025-04-23
NAPROXEN 250 MG TABLET	49483-0619-50	0.05176	EACH	2025-03-19
NAPROXEN 250 MG TABLET	49483-0619-01	0.05176	EACH	2025-03-19
NAPROXEN 250 MG TABLET	49483-0619-50	0.04377	EACH	2025-02-19

Best Wholesale Price for NDC 49483-0619

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for Naproxen (NDC: 49483-0619)

Naproxen, a widely used nonsteroidal anti-inflammatory drug (NSAID), has been a staple in pain management for decades. This article delves into the market analysis and price projections for Naproxen with the National Drug Code (NDC) 49483-0619, manufactured by Time Cap Laboratories, Inc.

Overview of Naproxen (NDC: 49483-0619)

Naproxen (NDC: 49483-0619) is a prescription drug produced by Time Cap Laboratories, Inc. It's available in tablet form and is primarily used to treat pain, tenderness, swelling, and stiffness[7]. As a popular NSAID, Naproxen plays a crucial role in managing various conditions, from arthritis to menstrual cramps.

Current Market Position

Time Cap Laboratories, Inc., the manufacturer of this specific Naproxen product, holds a significant position in the pharmaceutical market. Their Naproxen offering (NDC: 49483-0619) is available in packages of 100 tablets in 1 plastic bottle[7], catering to both individual and bulk purchase needs.

Pricing Structure

While specific pricing information for NDC 49483-0619 is not directly available in the provided search results, we can infer some insights based on industry trends and similar products.

According to the Centers for Medicare & Medicaid Services (CMS), "The Calendar Year 2025 reference data includes drug name and NDC information of all the drugs listed in the U.S. Food and Drug Administration (FDA) NDC Directory."[6]

This suggests that pricing information for Naproxen (NDC: 49483-0619) will be included in future CMS datasets, providing valuable insights for market analysis.

Market Trends Affecting Naproxen Pricing

Several factors influence the pricing of Naproxen and similar drugs in the pharmaceutical market:

1. Generic Competition

As a generic drug, Naproxen faces competition from other manufacturers, which typically leads to lower prices compared to brand-name alternatives.

2. Regulatory Changes

The pharmaceutical industry is heavily regulated, and changes in policies can significantly impact drug pricing. For instance, the Department of Labor's Office of Workers' Compensation Programs maintains a list of denied NDCs, which could affect the market demand for specific drug codes[8].

3. Supply Chain Disruptions

Global events, such as the recent pandemic, can disrupt supply chains and potentially affect drug availability and pricing.

4. Healthcare Reform

Ongoing discussions about healthcare reform in the United States could lead to changes in drug pricing structures and reimbursement rates.

Price Projections

While exact price projections for Naproxen (NDC: 49483-0619) are not available in the provided search results, we can make some educated predictions based on industry trends:

Short-term Projections

In the short term, prices for Naproxen are likely to remain relatively stable due to its status as a well-established generic drug. However, minor fluctuations may occur due to changes in raw material costs or short-term supply chain disruptions.

Long-term Projections

Looking further ahead, several factors could influence Naproxen pricing:

1. Increased competition from new generic manufacturers entering the market could put downward pressure on prices.

2. Technological advancements in drug manufacturing processes might lead to reduced production costs, potentially resulting in lower prices for consumers.

3. Changes in healthcare policies, such as those affecting drug pricing transparency or negotiations, could impact long-term pricing trends.

Comparative Analysis

To better understand the market position of Naproxen (NDC: 49483-0619), it's helpful to compare it with similar products:

Other Naproxen Products

Time Cap Laboratories, Inc. produces several Naproxen products with different strengths and formulations. For example:

• NDC 49483-0617: Another Naproxen product by the same manufacturer[5]
• NDC 49483-0609: Naproxen Sodium, a slightly different formulation[5]

These variations allow the company to cater to different patient needs and market segments.

Competitor Products

Other NSAIDs in the market include:

• Ibuprofen (e.g., NDC 49483-0114, also manufactured by Time Cap Laboratories, Inc.)[3]
• Aspirin (e.g., NDC 49483-0052, another Time Cap Laboratories, Inc. product)[3]

The presence of these alternatives in the market contributes to competitive pricing pressures on Naproxen.

Factors Influencing Future Demand

Several factors could impact the future demand for Naproxen (NDC: 49483-0619):

1. Aging Population

As the global population ages, the prevalence of conditions treated by NSAIDs, such as arthritis, is likely to increase, potentially driving up demand for Naproxen.

2. Shift Towards Personalized Medicine

Advancements in pharmacogenomics could lead to more personalized prescribing practices, potentially affecting the demand for specific NSAIDs like Naproxen.

3. Emerging Markets

Expanding access to healthcare in developing countries could open up new markets for Naproxen and similar drugs.

4. Alternative Therapies

The growing interest in alternative pain management techniques, such as acupuncture or medical marijuana, could impact the demand for traditional NSAIDs.

Regulatory Landscape

The regulatory environment plays a crucial role in shaping the market for pharmaceutical products like Naproxen:

FDA Oversight

The U.S. Food and Drug Administration (FDA) maintains the National Drug Code Directory, which includes information on drug products like Naproxen (NDC: 49483-0619)[4]. This oversight ensures product quality and safety, which can influence market demand and pricing.

Price Transparency Initiatives

Some states, like Texas, have implemented prescription drug price disclosure programs[10]. These initiatives aim to increase transparency in drug pricing, which could impact future pricing strategies for products like Naproxen.

Market Opportunities and Challenges

Opportunities

1. Expanding into new geographic markets
2. Developing extended-release or combination formulations
3. Exploring partnerships with healthcare providers or insurers

Challenges

1. Managing supply chain disruptions
2. Navigating changing regulatory landscapes
3. Differentiating from competitor products in a crowded market

Strategies for Market Success

To maintain and potentially improve its market position, Time Cap Laboratories, Inc. could consider the following strategies for Naproxen (NDC: 49483-0619):

1. Invest in research and development to improve drug efficacy or reduce side effects
2. Explore innovative packaging or delivery methods
3. Implement robust supply chain management to ensure consistent availability
4. Engage in strategic partnerships with healthcare providers or pharmacy benefit managers

Future Market Scenarios

Based on current trends and potential future developments, we can envision several possible scenarios for the Naproxen market:

Scenario 1: Status Quo

The market remains relatively stable, with minor fluctuations in pricing and demand driven by typical market forces.

Scenario 2: Increased Competition

New entrants to the generic NSAID market lead to increased price competition, potentially driving down prices for Naproxen.

Scenario 3: Technological Disruption

Advancements in pain management technologies or alternative therapies significantly impact the demand for traditional NSAIDs like Naproxen.

Scenario 4: Regulatory Overhaul

Major changes in healthcare policy or drug pricing regulations dramatically alter the market landscape for prescription drugs.

Key Takeaways

• Naproxen (NDC: 49483-0619) is a widely used NSAID manufactured by Time Cap Laboratories, Inc.
• The pricing and market position of this drug are influenced by factors such as generic competition, regulatory changes, and healthcare reform.
• While short-term prices are likely to remain stable, long-term projections are subject to various market forces and potential disruptions.
• The aging population and expanding healthcare access in emerging markets present opportunities for growth.
• Regulatory oversight and price transparency initiatives play crucial roles in shaping the market landscape.
• Future success in the market may depend on strategies such as product differentiation, supply chain optimization, and strategic partnerships.

FAQs

1. Q: How does the pricing of Naproxen (NDC: 49483-0619) compare to other NSAIDs? A: While specific pricing information isn't available in the provided search results, as a generic drug, Naproxen typically offers competitive pricing compared to brand-name NSAIDs.

2. Q: Are there any upcoming regulatory changes that could affect Naproxen pricing? A: While no specific changes are mentioned in the search results, ongoing discussions about healthcare reform and drug pricing transparency could potentially impact future pricing.

3. Q: How might the aging global population affect the demand for Naproxen? A: An aging population could lead to increased prevalence of conditions treated by NSAIDs, potentially driving up demand for drugs like Naproxen.

4. Q: What strategies could Time Cap Laboratories, Inc. employ to maintain its market position? A: Potential strategies include investing in R&D, exploring new formulations or delivery methods, optimizing supply chain management, and forming strategic partnerships.

5. Q: How might emerging pain management technologies impact the market for Naproxen? A: Advancements in alternative pain management techniques could potentially reduce demand for traditional NSAIDs like Naproxen, though the extent of this impact remains to be seen.

Sources cited: [3] https://www.findacode.com/ndc/labelers/TIME_CAP_LABS_INC--49483 [4] https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information [5] https://www.findacode.com/ndc/labelers/TIME_CAP_LABORATORIES_INC.--49483 [6] https://www.cms.gov/openpayments/downloads/drug-name-and-ndc-reference-data-instructions.pdf [7] https://ndclist.com/ndc/49483-619/package/49483-619-01 [8] https://www.dol.gov/agencies/owcp/FECA/not_covered_ndc [10] https://www.dshs.texas.gov/prescription-drug-price-disclosure-program/glossary